Sydney Lupkin
speaker
1,036 appearances
105 recordings
3 series
first heard Dec 2024
last heard 2d ago
Sydney Lupkin’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 90 in all, peaking in Jul 2026 with 21.
Appearances
The drug company is also suing companies that sell so-called research-only peptides online.
matched
Retrotrutide is currently in phase three clinical trials.
matched
Because it targets three hormones, GLP-1, GIP, and glucagon, it's more powerful than GLP-1s already on the market.
matched
However, since retrotrutide isn't FDA-approved,
matched
Compounding it, repackaging it, or selling its active ingredient to compounders is illegal, the FDA says.
matched
Unapproved products may be contaminated, contain too much or too little of the active ingredient, or be counterfeit products that contain none at all.
matched
Sydney Lupkin, NPR News.
matched
Eli Lilly says it has filed six lawsuits against businesses selling what it calls black market reditrutide.
matched
They include a medical spa chain in California and a compounding pharmacy in Texas.
matched
The drug company is also suing companies that sell so-called research-only peptides online.
matched
Retitrutide is currently in phase three clinical trials.
matched
Because it targets three hormones, GLP one, GIP, and glucagon, it's more powerful than GLP one's already on the market.
matched
However, since retitrutide isn't FDA approved,
matched
Compounding it, repackaging it, or selling its active ingredient to compounders is illegal, the FDA says.
matched
Unapproved products may be contaminated, contain too much or too little of the active ingredient, or be counterfeit products that contain none at all.
matched
Sydney Lupin, NPR News.
matched
They include a medical spa chain in California and a compounding pharmacy in Texas.
matched
The drug company is also suing companies that sell so-called research-only peptides online.
matched
Retitrutide is currently in phase three clinical trials.
matched
Because it targets three hormones, GLP1, GIP, and glucagon, it's more powerful than GLP one's already on the market.
matched
Showing 221–240 of 1,036 · page 12 of 52
← Previous
Next →